Sera Prognostics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 124.8K | $253.33K | 0.00% | Unchanged | 2026-03-31 |
| TwoSigma | quant | 22.0K | $44.59K | 0.00% | Unchanged | 2026-03-31 |
| FidelityFMR | fundamental | 6.6K | $13.34K | 0.00% | Trimmed-55.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -0.19 | — | — |
| 2026-05-06 | -0.17 | -0.17 | +1.92% |
| 2026-03-18 | -0.19 | -0.16 | +15.79% |
| 2025-11-13 | -0.21 | -0.16 | +23.81% |
| 2025-08-06 | -0.24 | -0.16 | +33.33% |
| 2025-05-07 | -0.21 | -0.20 | +4.76% |
| 2025-03-19 | -0.24 | -0.25 | -4.17% |
| 2024-11-06 | -0.22 | -0.24 | -9.09% |
| 2024-08-07 | -0.26 | -0.25 | +5.66% |
| 2024-05-08 | -0.27 | -0.25 | +7.41% |
| 2024-03-20 | -0.26 | -0.25 | +3.85% |
| 2023-11-08 | -0.35 | -0.23 | +35.12% |
| 2023-08-09 | -0.36 | -0.34 | +4.70% |
| 2023-05-10 | -0.38 | -0.34 | +11.14% |
| 2023-03-22 | -0.33 | -0.32 | +3.50% |
| 2022-11-09 | -0.62 | -0.35 | +43.48% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| SERA | +13.09% | +6.93% | -26.78% | +36.71% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | +10.12% | +11.76% | -23.34% | +24.09% |